Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Viemed Healthcare (VMD) EBIT Margin (2018 - 2025)

Viemed Healthcare (VMD) has disclosed EBIT Margin for 6 consecutive years, with 10.99% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIT Margin rose 36.0% year-over-year to 10.99%, compared with a TTM value of 8.49% through Dec 2025, up 51.0%, and an annual FY2025 reading of 8.49%, up 51.0% over the prior year.
  • EBIT Margin was 10.99% for Q4 2025 at Viemed Healthcare, up from 7.85% in the prior quarter.
  • Across five years, EBIT Margin topped out at 14.6% in Q4 2021 and bottomed at 3.01% in Q2 2022.
  • Average EBIT Margin over 5 years is 7.88%, with a median of 7.96% recorded in 2025.
  • The sharpest move saw EBIT Margin crashed -2028bps in 2021, then soared 441bps in 2023.
  • Year by year, EBIT Margin stood at 14.6% in 2021, then crashed by -35bps to 9.42% in 2022, then grew by 11bps to 10.42% in 2023, then grew by 2bps to 10.63% in 2024, then grew by 3bps to 10.99% in 2025.
  • Business Quant data shows EBIT Margin for VMD at 10.99% in Q4 2025, 7.85% in Q3 2025, and 8.08% in Q2 2025.